Directory
Marta Vaquero Susagna

Marta Vaquero Susagna

Degree: PhD

973 70 2213
mvaquero(ELIMINAR)@gss.cat

Publications

  • Anerillas, C; Perramon-Güell, A; Altes, G; Cuesta, S; Vaquero, M; Olomi, A; Rodriguez-Barrueco, R; Llobet-Navàs, D; Egea, J; Dolcet, X; Yeramian, A; Encinas, M

    Sprouty1 is a broad mediator of cellular senescence

    CELL DEATH & DISEASE 15 296-296. .

    [doi:10.1038/s41419-024-06689-4]

  • Dorca, E; Velasco, A; Varela, M; Gatius, S; Villatoro, S; Fullana, N; Cuevas, D; Vaquero, M; Birnbaum, A; Neumann, K; Matias-Guiu, X

    Validation of Modaplex POLE mutation assay in endometrial carcinoma

    VIRCHOWS ARCHIV 483 787-794. .

    [doi:10.1007/s00428-023-03636-0]

  • Altes, G; Vaquero, M; Cuesta, S; Anerillas, C; Macia, A; Espinet, C; Ribera, J; Bellusci, S; Klein, OD; Yeramian, A; Dolcet, X; Egea, J; Encinas, M

    A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

    Cellular And Molecular Life Sciences 79 514-514. .

    [doi:10.1007/s00018-022-04546-1]

  • Cuevas, D; Velasco, A; Vaquero, M; Santacana, M; Gatius, S; Eritja, N; Estaran, E; Matias-Guiu, X

    Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY.

    Histopathology 76 447-460. .

    [doi:10.1111/his.14001]

  • Vaquero, M; Cuesta, S; Anerillas, C; Altes, G; Ribera, J; Basson, MA; Licht, JD; Egea, J; Encinas, M

    Sprouty1 Controls Genitourinary Development via its N-Terminal Tyrosine

    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 30 1398-1411. .

    [doi:10.1681/ASN.2018111085]

  • Cuevas, D; Valls, J; Gatius, S; Roman-Canal, B; Estaran, E; Dorca, E; Santacana, M; Vaquero, M; Eritja, N; Velasco, A; Matias-Guiu, X

    Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    VIRCHOWS ARCHIV 474 585-598. .

    [doi:10.1007/s00428-018-02516-2]

  • Dosil, MA; Navaridas, R; Mirantes, C; Tarragona, J; Eritja, N; Felip, I; Urdanibia, I; Megino, C; Domingo, M; Santacana, M; Gatius, S; Piñol C; Barcelo, C; Maiques, O; Macia, A; Velasco, A; Vaquero, M; Matias-Guiu, X; Dolcet, X

    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    JOURNAL OF PATHOLOGY 247 72-85. .

    [doi:10.1002/path.5168]

  • Gou-Fabregas, M; Macia, A; Anerillas, C; Vaquero, M; Jove, M; Jain, S; Ribera, J; Encinas, M

    7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome

    SCIENTIFIC REPORTS 6 28534-28534. .

    [doi:10.1038/srep28534]

  • Vaquero, M; Macia, A; Anerillas, C; Velasco, A; Matias-Guiu, X; Ribera, J; Encinas, M

    Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten(+/-) mice

    ENDOCRINE-RELATED CANCER 23 7-11. .

    [doi:10.1530/ERC-15-0585]

  • Macià A; Vaquero M; Gou-Fàbregas M; Castelblanco E; Valdivielso JM; Anerillas C; Mauricio D; Matias-Guiu X; Ribera J; Encinas M

    Sprouty1 induces a senescence-associated secretory phenotype by regulating NFjB activity: implications for tumorigenesis

    CELL DEATH AND DIFFERENTIATION 21 333-343. .

    [doi:10.1038/cdd.2013.161]

  • Armengol, AM; Susagna, MV; Gou-Fabregas, M; Santacana, M; VILARDELL, F; Matias-Guiu, X; Martin, ME

    Loss of Sprouty1 accelerates PTEN-induced tumor formation by suppressing cellular senescence

    FEBS Journal 279 167-167. .

  • Macia, A.; Gallel, P.; Vaquero, M.; Gou-Fabregas, M.; Santacana, M.; Maliszewska, A.; Robledo, M.; Gardiner, J. R.; Basson, M. A.; Matias-Guiu, X.; Encinas, M.

    Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

    ONCOGENE 31 3961-3972. .

    [doi:10.1038/onc.2011.556]

Projects

  • Exploring vulnerabilities of medullary thyroid carcinoma beyond Ret kinase inhibition
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812